UnknownNot Applicable

Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.

Canada30 participantsStarted 2019-09-27

Plain-language summary

The study is looking at the role of the mesentery in disease recurrence for ileocolic Crohn's disease. It is a prospective study that has been designed to perform extended mesenteric excision on patients undergoing their first ileocolic resection for Crohn's disease. Endoscopic recurrence will be monitored with the hypothesis that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults \>18 years old * diagnosis of CD limited to the distal ileum/ileocolic region * no previous ileocolic resection * all forms of CD presentation will be included - stricturing, fistulizing, perforating etc. Exclusion Criteria: * previous ileocolic resection * other sites of CD * intraabdominal sepsis

What they're measuring

Number of participants with endoscopic recurrence at 6 months

Timeframe: 6 months

Trial details

NCT IDNCT04539665

SponsorMontreal General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-30

Contact for this trial

Sender Liberman, MD

(514) 934-8486 sender.liberman@mcgill.ca

View on ClinicalTrials.gov More Crohn Disease trials